Ionis Pharmaceuticals (IONS)
(Delayed Data from NSDQ)
$48.00 USD
+0.69 (1.46%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $47.96 -0.04 (-0.08%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/14/24 |
---|---|
Current Quarter | -1.03 |
EPS Last Quarter | -0.98 |
Last EPS Surprise | 10.91% |
ABR | 1.74 |
Earnings ESP
|
26.87% |
---|---|
Current Year | -3.91 |
Next Year | -3.38 |
EPS (TTM) | -2.67 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 141.68M | 152.07M | 592.80M | 732.73M |
# of Estimates | 8 | 8 | 8 | 8 |
High Estimate | 166.90M | 168.10M | 641.70M | 867.71M |
Low Estimate | 125.44M | 120.86M | 542.88M | 640.40M |
Year ago Sales | 188.00M | 144.00M | 788.00M | 592.80M |
Year over Year Growth Est. | -24.64% | 5.60% | -24.77% | 23.60% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.03 | -1.03 | -3.91 | -3.38 |
# of Estimates | 9 | 8 | 9 | 10 |
Most Recent Consensus | -0.75 | -0.82 | -3.34 | -2.21 |
High Estimate | -0.75 | -0.82 | -3.34 | -2.21 |
Low Estimate | -1.20 | -1.29 | -4.47 | -4.61 |
Year ago EPS | -0.60 | -1.03 | -2.56 | -3.91 |
Year over Year Growth Est. | -71.67% | 0.00% | -52.73% | 13.51% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 3 |
Up Last 60 Days | 3 | 2 | 3 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 2 | 0 |
Down Last 60 Days | 0 | 2 | 3 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.03 | -1.03 | -3.91 | -3.38 |
7 Days Ago | -1.03 | -1.03 | -3.91 | -3.38 |
30 Days Ago | -1.03 | -1.03 | -3.93 | -3.40 |
60 Days Ago | -1.04 | -1.01 | -3.96 | -3.38 |
90 Days Ago | -1.09 | -1.07 | -4.00 | -3.54 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.75 | -0.82 | -3.76 | -2.94 |
Zacks Consensus Estimate | -1.03 | -1.03 | -3.91 | -3.38 |
Earnings ESP | 26.87% | 20.30% | 3.89% | 13.22% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.98 | -0.06 | -1.03 | -0.60 | NA |
Estimate | -1.10 | -0.78 | -1.01 | -0.94 | NA |
Difference | 0.12 | 0.72 | -0.02 | 0.34 | 0.29 |
Surprise | 10.91% | 92.31% | -1.98% | 36.17% | 34.35% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more